NV 50
Alternative Names: NV50Latest Information Update: 12 Dec 2017
At a glance
- Originator Novogen
- Class
- Mechanism of Action Estrogen receptor antagonists; Signal transduction pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 04 Mar 2008 Discontinued - Preclinical for Breast cancer in Australia (unspecified route)
- 24 Apr 2007 No development reported - Preclinical for Breast cancer in Australia (unspecified route)
- 12 Nov 2001 New profile